SCHEMBL457715

SCHEMBL457715

IC1CCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2596793 1.00
SCHEMBL470814 1.00
SCHEMBL18290970 0.81
SCHEMBL18291426 0.81
SCHEMBL8520744 0.81
SCHEMBL172959 0.79
SCHEMBL30675853 0.76
SCHEMBL359615 0.73
SCHEMBL16281770 0.71
SCHEMBL16281778 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 374 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110452146-A Trifluoromethyl seleno-amino acids derivative and preparation method thereof UNIV WUHAN TECH 2019-11-15 CN claimed
EP-0691964-B1 (3-KETOTETRAHYDROFURAN-2-YL)ETHANAL DERIVATIVES AND A METHOD FOR THEIR PREPARATION BIOCURE LTD (GB) 1998-09-02 EP claimed
US-5684166-A MULTISTAGE REACTION OF TRANS-HEXEN-3-ENE-1,6-DIOL TO AN IODO ETHERIFICATION REACTION TO GIVE 3-IODOTETRAHYDROFURAN, PROTECTION OF HYDROXYL AND DISPLACEMENT OF IODINE FOR PRODUCT BIOCURE LIMITED (GB) 1997-11-04 US claimed
EP-0691964-A1 (3-KETOTETRAHYDROFURAN-2-YL)ETHANAL DERIVATIVES AND A METHOD FOR THEIR PREPARATION BIOCURE LIMITED (GB) 1996-01-17 EP claimed
WO-1994022849-A1 (3-KETOTETRAHYDROFURAN-2-YL)ETHANAL DERIVATIVES AND A METHOD FOR THEIR PREPARATION BIOCURE LIMITED (GB) 1994-10-13 WO claimed
US-12637468-B2 Substituted [1,2,4]triazolo[4,3-b]pyridazines as GABAA receptor modulators Shanghai Simr Biotechnology Co., Ltd. (CN) 2026-05-26 US disclosed
WO-2026103316-A1 TETRAHYDROFURAN-FORMAMIDE SODIUM CHANNEL MODULATOR AND USE THEREOF IN MEDICINE 嘉兴安帝康生物科技有限公司 2026-05-21 WO disclosed
US-12630737-B2 Radiation sensitive organotin compositions having oxygen heteroatoms in hydrocarbyl ligand INPRIA CORPORATION (US) 2026-05-19 US disclosed
US-20260116881-A1 KIF MODULATOR COMPOUNDS AND METHODS OF USE IAMBIC THERAPEUTICS INC (US) 2026-04-30 US disclosed
US-20260109677-A1 COMPOUNDS, DEVICES, AND USES THEREOF SIGILON THERAPEUTICS INC (US) 2026-04-23 US disclosed
US-12606544-B2 JAK1 selective kinase inhibitor DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) 2026-04-21 US disclosed
EP-4720068-A1 COMPOUNDS FOR THE DEGRADATION OF EGFR KINASE Beone Medicines I GmbH (CH) 2026-04-08 EP disclosed
US-7049312-B1 Benzothiazinone and benzoxazinone compounds ABBOTT GMBH & CO. KG (DE) 2006-05-23 US disclosed
CN-1636005-A Benzothiazinone and benzoxazinone compounds KNOLL AG (DE) 2005-07-06 CN disclosed
EP-1181282-A2 BENZOTHIAZINONE AND BENZOXAZINONE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2002-02-27 EP disclosed
WO-2000075139-A2 BENZOTHIAZINONE AND BENZOXAZINONE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2000-12-14 WO disclosed
EP-0691964-B1 (3-KETOTETRAHYDROFURAN-2-YL)ETHANAL DERIVATIVES AND A METHOD FOR THEIR PREPARATION BIOCURE LTD (GB) 1998-09-02 EP disclosed
US-5684166-A MULTISTAGE REACTION OF TRANS-HEXEN-3-ENE-1,6-DIOL TO AN IODO ETHERIFICATION REACTION TO GIVE 3-IODOTETRAHYDROFURAN, PROTECTION OF HYDROXYL AND DISPLACEMENT OF IODINE FOR PRODUCT BIOCURE LIMITED (GB) 1997-11-04 US disclosed
EP-0691964-A1 (3-KETOTETRAHYDROFURAN-2-YL)ETHANAL DERIVATIVES AND A METHOD FOR THEIR PREPARATION BIOCURE LIMITED (GB) 1996-01-17 EP disclosed
WO-1994022849-A1 (3-KETOTETRAHYDROFURAN-2-YL)ETHANAL DERIVATIVES AND A METHOD FOR THEIR PREPARATION BIOCURE LIMITED (GB) 1994-10-13 WO disclosed